-
THE POLICY CASE FOR PAEDIATRIC INFLUENZA VACCINATION STRATEGIES: LAIV MODELING ANALYSIS OF PUBLIC HEALTH IMPACT AND COST SAVINGS IN EUROPE
Aug 25, 2026, 15:53 PM -
IMPROVING INFLUENZA VACCINATION UPTAKE AMONG HEALTHCARE PROFESSIONALS: A GLOBAL UMBRELLA REVIEW IDENTIFYING BEHAVIORAL AND SYSTEM-LEVEL LEVERS FOR POLICY ACTION
Aug 25, 2026, 15:53 PM -
PHARMACIST-LED VACCINATION IN FRANCE: DRIVERS OF ACCEPTABILITY ACROSS HEALTHCARE USERS, GENERAL PRACTITIONERS, AND PHARMACISTS
Aug 25, 2026, 15:53 PM -
From Evidence to Elimination: A Decade of HEOR informing Taiwan's National Hepatitis C DAA Reimbursement Policy
Aug 20, 2026, 15:06 PM -
Regulatory Assessment of Emergency and Critical Care Services in Dubai: Using Evidence to Drive System-Level Reform
Aug 20, 2026, 15:06 PM -
The Impact of HTA on Vitamin D Testing in Switzerland
Aug 20, 2026, 15:06 PM -
Determinants of Unregistered Medicines Importation in Saudi Arabia: A National Regulatory Analysis
Aug 20, 2026, 15:06 PM -
Scan-2030: building a decision-ready health technology assessment ecosystem in hong kong for sustainable access to innovative medicines
Aug 20, 2026, 15:06 PM -
Implementing Value-Based Care in Maxillofacial Procedures: A Pilot Study on Protocol-Driven Decision Making, Economic Outcomes, and Patient Satisfaction in a Brazilian Payer System
Aug 20, 2026, 15:06 PM -
DEVELOPING A MULTI-COUNTRY MICROSIMULATION TO ESTIMATE THE FUTURE IMPACT OF GUIDELINE-DIRECTED MEDICAL THERAPY ON POTENTIALLY AVOIDABLE HOSPITALISATIONS AND RELATED ECONOMIC, SOCIETAL, AND ENVIRONMENTAL OUTCOMES: GLOBALPAH
Aug 11, 2026, 17:16 PM -
WHAT DO THE FIRST EU JOINT CLINICAL ASSESSMENT COHORTS REVEAL ABOUT FUTURE EVIDENCE EXPECTATIONS? EARLY INSIGHTS FOR MANUFACTURERS AND HTA STAKEHOLDERS
Aug 11, 2026, 17:16 PM -
MEASURING RETURN ON INVESTMENT IN REAL-WORLD DATA, EVIDENCE, AND INSIGHTS: RESULTS FROM THE 2025 REAL-WORLD LEADERS FORUM BENCHMARK SURVEY
Aug 11, 2026, 17:16 PM -
FORGONE HEALTH FROM RESTRICTED ONCOLOGY ACCESS UNDER MOST-FAVORED-NATION PRICING: A TWO-MARGIN FRAMEWORK WITH A BREAST CANCER ILLUSTRATION
Aug 11, 2026, 17:16 PM -
DOES IRELAND NEED GENETIC TESTING? A HEALTH ECONOMICS PERSPECTIVE ON IRISH PRESCRIBING TRENDS, ADVERSE DRUG REACTIONS AND THE IMPACT OF PHARMACOGENOMIC TESTING
Aug 11, 2026, 17:16 PM -
BUDGET IMPACT OF SEMAGLUTIDE LOSS-OF-EXCLUSIVITY IN TYPE 2 DIABETES IN CANADA
Aug 11, 2026, 17:16 PM -
SOCIOECONOMIC INEQUALITIES IN UNMET DENTAL CARE NEEDS IN GREECE: EVIDENCE FROM EU-SILC 2024
Aug 11, 2026, 17:16 PM -
ADDRESSING EVIDENCE GAPS THROUGH STRUCTURED EXPERT ELICITATION: INSIGHTS FROM RECENT NICE TECHNOLOGY APPRAISALS
Aug 11, 2026, 17:16 PM -
EQUITY GAPS IN ACCESS TO ESSENTIAL CARDIOVASCULAR AND ANTIDIABETIC MEDICINES IN PAKISTAN: A MULTI-REGIONAL WHO/HAI SURVEY WITH MULTIVARIABLE ANALYSIS
Aug 11, 2026, 17:16 PM -
A POOLED REAL-WORLD CASE ANALYSIS OF BIOMARKER-GUIDED TREATMENT PATTERNS AND CLINICAL BURDEN IN BING-NEEL SYNDROME
Aug 11, 2026, 17:16 PM -
COST-EFFECTIVENESS ANALYSIS OF EARLY IMMUNOTHERAPY AND TARGETED THERAPY FOR NSCLC IN BULGARIA
Aug 11, 2026, 17:16 PM
